About Theros Pharmaceutical
Theros Pharmaceutical is a Consumer company based in Newcastle Upon Tyne (United Kingdom) founded in 2012, and was acquired by Wayland in November 2018. Medical cannabis products are developed and branded by Theros Pharmaceutical. Its focus areas include Retail, Cannabis Brands and Retailers, Brands and Application Specific. Its competitors include CiiTECH, De La Vida CBD and Breathe Life Sciences; 1 of its 3 listed competitors has raised funding.
Company details
Theros Pharmaceutical was established in 2012 in Newcastle Upon Tyne, United Kingdom. Focus is placed on the pharmaceutical sector, particularly the creation and branding of medical cannabis products. Operations involve research, production, and distribution of cannabis-based treatments for medical applications. Services are tailored to regulatory standards in the UK market, with emphasis on therapeutic solutions derived from cannabis. The companys domain, thero.co, supports its online presence and stakeholder engagement.
Investors in Theros Pharmaceutical
Theros Pharmaceutical has secured backing from 1 investor. Prominent investors backing the company include Wayland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufactures high-quality medical cannabis products for healthcare applications. | 2013 | waylandgroup.com | Burlington, Canada |
Investor details for Theros Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Theros Pharmaceutical
2 dated milestones of Theros Pharmaceutical across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Theros Pharmaceutical is founded.
- Exit Acquired by Wayland.
Competitors of Theros Pharmaceutical
Theros Pharmaceutical has 3 listed competitors in our database, 1 of them funded. They include CiiTECH, De La Vida CBD and Breathe Life Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ciitech.co.il | 2017 | London, United Kingdom | $2.91M | Cannabis therapeutics for neurological disorders and others are developed. | ||
| delavidacbd.com | 2019 | Sandown, United Kingdom | Operates as a brand specializing in cannabis oils and tinctures. | |||
| breathelifesciences.com | 2021 | London, United Kingdom | Brand of cannabis medical, health, and wellness products |
Detailed competitors of Theros Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Theros Pharmaceutical
Complete news archive for Theros Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Theros Pharmaceutical
Theros Pharmaceutical was founded in 2012.
Theros Pharmaceutical is headquartered in Newcastle Upon Tyne, United Kingdom.
Theros Pharmaceutical was established in 2012 in Newcastle Upon Tyne, United Kingdom. Focus is placed on the pharmaceutical sector, particularly the creation and branding of medical cannabis products. Operations involve research, production, and distribution of cannabis-based treatments for medical applications. Services are tailored to regulatory standards in the UK market, with emphasis on therapeutic solutions derived from cannabis. The companys domain, thero.co, supports its online presence and stakeholder engagement.
Theros Pharmaceutical's top competitors include CiiTECH, Breathe Life Sciences and De La Vida CBD.
Theros Pharmaceutical has 1 investor. Key investors include Wayland.
Yes. Theros Pharmaceutical was acquired by Wayland in November 2018.